The use of the biosimilar drug can lead to large health care savings that can be reinvested for continued innovation: Analysis of consumption of an Italian health care company
- Resource Type
- Article
- Source
- In
Journal of Cancer Policy June 2024 40 - Subject
- Language
- ISSN
- 2213-5383